Description

Avastin (bevacizumab) concentrate for infusions 400 mg/16 ml. №1 vial

Ingredients

Active ingredient: Bevacizumab. Inactive ingredients may include sodium chloride, polysorbate 20, and water for injection.

Dosage

Dosage: The recommended dose of Avastin is 5 mg/kg of body weight administered as an intravenous infusion every 2 weeks.

Indications

Indications: Avastin is indicated for the treatment of various cancers, including colorectal, lung, breast, and kidney cancer.

Contraindications

Contraindications: Avastin is contraindicated in patients with a history of severe allergic reactions to bevacizumab or any of the excipients in the formulation.

Directions

Administration: Avastin should be administered by a healthcare professional experienced in the use of anticancer therapies.

Scientific Evidence

Efficacy: Several clinical trials have demonstrated the efficacy of Avastin in the treatment of various cancers. For example, a study published in the Journal of Clinical Oncology showed that Avastin, when combined with chemotherapy, significantly improved progression-free survival in patients with metastatic colorectal cancer.

Additional Information

Storage: Store Avastin in the refrigerator at 2°C to 8°C. Do not freeze. Protect from light. Once removed from the refrigerator, the product should be used within 8 hours if stored at 2°C to 8°C.

Avastin works by inhibiting the formation of new blood vessels, a process called angiogenesis, that tumors need to grow and spread. By blocking this process, Avastin helps to slow or stop tumor growth.

Clinical trials have shown that Avastin, in combination with other cancer treatments, can improve outcomes for patients with certain types of cancer. It is important to discuss the potential benefits and risks of Avastin treatment with your healthcare provider.